Molecular cytogenetics as a clinical test for prognostic and predictive biomarkers in newly diagnosed ovarian cancer-Reference-Cited by-同舟云学术

Molecular cytogenetics as a clinical test for prognostic and predictive biomarkers in newly diagnosed ovarian cancer

Published:2013 Issue:1 Volume:6 Page:2
ISSN:1757-2215
Container-title:Journal of Ovarian Research
language:en
Short-container-title:Journal of Ovarian Research

Author:

Gunn Shelly,Reveles Xavier,Weldon Korrie,Barrera Andres,Ishaque Mariam,Taylor Dale,McCaskill Chris,Kim Jaeweon,Shah Rashmi,Mohammed Mansoor,Barry Todd,Kaiser Brianne,Patnaik Amita,Tolcher Anthony

Publisher

Springer Science and Business Media LLC

Subject

Obstetrics and Gynecology,Oncology

Reference15 articles.

1. Phase III Trial of Satraplatin, an Oral Platinum plus Prednisone vs. Prednisone alone in Patients with Hormone-Refractory Prostate Cancer

2. The therapeutic potential of targeting the EGFR family in epithelial ovarian cancer

3. Fusion of EML4 and ALK is associated with development of lung adenocarcinomas lacking EGFR and KRAS mutations and is correlated with ALK expression

4. Amplicon-Dependent CCNE1 Expression Is Critical for Clonogenic Survival after Cisplatin Treatment and Is Correlated with 20q11 Gain in Ovarian Cancer

5. Integrated genomic analyses of ovarian carcinoma

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting tumour markers in ovarian cancer treatment;Clinica Chimica Acta;2024-06

2. Exploring the Clinical Impact of Predictive Biomarkers in Serous Ovarian Carcinomas;Current Drug Targets;2020-07-28

3. A 4-month-old boy with gastrointestinal stromal tumor of mesocolon;Cancer Biology & Therapy;2018-09-25

4. Reference Size Matching, Whole-Genome Amplification, and Fluorescent Labeling as a Method for Chromosomal Microarray Analysis of Clinically Actionable Copy Number Alterations in Formalin-Fixed, Paraffin-Embedded Tumor Tissue;The Journal of Molecular Diagnostics;2018-05

5. Prediction of therapy response in ovarian cancer: Where are we now?;Critical Reviews in Clinical Laboratory Sciences;2017-04-26